官方服务：
资源简介：
数据来源于邯郸市邯郸明仁医院。在提供his系统中产生。包括患者的基本信息、出院时间、入院时间、出院结算时间、医生，参保信息。用于用药监督与疗效评估场景
应用场景：
提供机构：
邯郸明仁医院相关数据集
Comparison of baseline characteristics between responder and non-responder.
Comparison of baseline characteristics between responder and non-responder.
NIAID Data Ecosystem70
An Observational Study of Adjuvant Treatment With Capecitabine (Xeloda) in Combination With Oxaliplatin in Participants With Stage III Colon Cancer
This observational study evaluates the efficacy and safety of capecitabine in combination with oxaliplatin in the adjuvant setting in participants with Stage III colon cancer. Data were collected from
NIAID Data Ecosystem40
Association between the M-CHARTS score 12 months after initiating intravitreal ranibizumab therapy and baseline parameters in eyes with branch retinal vein occlusion.
Association between the M-CHARTS score 12 months after initiating intravitreal ranibizumab therapy and baseline parameters in eyes with branch retinal vein occlusion.
Figshare2018-09-20 更新20
Unweighted absolute risks and number needed to treat (NNT) for events of interest after 10 years of follow-up.
95% CI, 95% confidence intervals. ER, estrogen receptor. *Negative value suggests more events in extended adjuvant group (i.e. net harm).
NIAID Data Ecosystem60
Quality health indicators achieved over the first 12 months of observation, stratified by treatment allocation (N = 818).
Quality health indicators achieved over the first 12 months of observation, stratified by treatment allocation (N = 818).
Figshare2022-11-02 更新30
